Quality of life of patients with cardiomyopathy treated with sacubitril/valsartan vs. standard therapy during or after COVID-19 in Kazakhstan
The objective of this study is to evaluate the quality of life (QoL) of hospitalised patients with cardiomyopathy (CM) treated with a fixed dose combination (FDC) of sacubitril/valsartan, or standard therapy in Kazakhstan during or after COVID-19. This is an observational study of patients with inci...
Spremljeno u:
Glavni autori: | , , , , , |
---|---|
Format: | Knjiga |
Izdano: |
Pensoft Publishers,
2024-06-01T00:00:00Z.
|
Teme: | |
Online pristup: | Connect to this object online. |
Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|
Internet
Connect to this object online.3rd Floor Main Library
Signatura: |
A1234.567 |
---|---|
Primjerak 1 | Dostupno |